07:00 , Jun 1, 1999 |  BC Week In Review  |  Company News

Aurora management update

Aurora Biosciences Corp. (ABSC), San Diego, Calif.   Business: Drug discovery   Hired: Stuart Collinson as president, formerly CEO of Andaris Ltd.   Promoted: Harry Stylli to SVP of commercial development from SVP of screen...
08:00 , Feb 1, 1999 |  BC Week In Review  |  Company News

Quadrant drug delivery news

QTH will divest its Quantison and Myomap diagnostic imaging products acquired in its acquisition of Andaris Ltd. (see BioCentury Nov. 16 and Oct. 5, 1998). Quantison is in Phase II trials to diagnose cardiovascular disease....
08:00 , Jan 4, 1999 |  BioCentury  |  Finance

Two sides of the Euro coin

London & the Continent Two sides of the Euro coin OXFORD - There can be little doubt that 1998 was another annus horribilis for the U.K. biotech sector, following a bad 1997. The sector was...
08:00 , Nov 16, 1998 |  BC Week In Review  |  Company News

Quadrant management update

(Acquisition completed, B2) Quadrant Healthcare plc (LSE:QTH), Cambridge, U.K.   Business: Drug delivery   Promoted: Jaap Kampings to CSO and director of research, formerly director of R&D   Hired: Terence Chadwick as R&D director, previously...
08:00 , Nov 16, 1998 |  BC Week In Review  |  Company News

Andaris, Quadrant deal

QTH completed its acquisition of Andaris (see BioCentury Oct. 5). (Management, B7) Andaris Ltd., Nottingham, U.K.   Quadrant Healthcare plc (LSE:QTH), Cambridge, U.K.   Business: Drug delivery  ...
07:00 , Oct 5, 1998 |  BC Week In Review  |  Company News

Andaris, Quadrant deal

QTH will acquire Andaris, a developer of microparticle-based technology for drug delivery. QTH will pay £13 million (US$22 million) for all shares of Andaris stock and will issue 16.7 million ordinary shares to Andaris shareholders....
07:00 , Oct 5, 1998 |  BioCentury  |  Finance

Selling on deals

QTH had been interested in accessing Andaris' microparticle technology but discovered that Gist-brocades, which owned 70 percent of Andaris' stock, wanted to exit. Although Gist-brocades was looking for cash, QTH is offering 16.8 million shares...
07:00 , Oct 5, 1998 |  BioCentury  |  Finance

Global woes bode worse for biotech

Eurostocks Global woes bode worse for biotech No matter how good the news coming from U.K. biotech companies, investors have continued to ignore the sector. Now, with the global market downturn, it has become even...
07:00 , Jun 22, 1998 |  BC Week In Review  |  Company News

Andaris management update

Andaris Ltd. , Nottingham, U.K.   Business: Diagnostics/Imaging   Hired: Stuart Collinson as CEO and a director, formerly therapy area director at Glaxo Wellcome  ...
07:00 , Jun 22, 1998 |  BC Week In Review  |  Company News

Andaris Ltd board of directors update

Andaris Ltd ., Nottingham, U.K.   Business: Diagnostics/Imaging   Retired: Co-founder David Heath as chairman, to become non-executive director   Appointed: Gordon Hall as non-executive chairman, formerly managing director of Shield Diagnostics  ...